Global Substance Abuse Treatment Market 2017-2021

物質乱用治療の世界市場2017-2021

◆タイトル:Global Substance Abuse Treatment Market 2017-2021
◆商品コード:IRTNTR13568
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年6月14日
◆ページ数:73
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、物質乱用治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、物質乱用治療の世界市場規模及び予測などの情報をお届けいたします。

About Substance Abuse TreatmentSubstance abuse is defined as an illicit use of alcohol, drugs, or cigarettes. They are potentially addictive in nature, difficult to treat, and have a negative impact on body and overall health. The major factors driving the market is the increase in substance usage and the number of associated deaths. It is also identified as a high economic burden. Substance abuse is one of the primary causes of death globally and a major economic burden. Substance abuse, along with addiction is associated with a variety of chronic diseases.

Technavio’s analysts forecast the global substance abuse treatment market to grow at a CAGR of 5.15% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global substance abuse treatment market for 2017-2021. To calculate the market size, the report considers the sales from both generic and branded drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Substance Abuse Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Alkermes
• Allergan
• GSK
• Pfizer

[Other prominent vendors]
• Accord Healthcare
• Amphastar Pharmaceuticals
• Apotex
• BioCorRx
• Cipla
• Glenmark
• INSYS Therapeutics
• LFB Group
• Lupin
• Mylan Laboratories
• Opiant Technologies
• Sanofi Aventis
• Sanquin
• Sterinova
• Sun Pharma
• Teva Pharmaceutical

[Market driver]
• Multiple facets of treatment
• For a full, detailed list, view our report

[Market challenge]
• High cost of treatment
• For a full, detailed list, view our report

[Market trend]
• Consolidation of rehabilitation centers
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive Summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: An overview of diseases related to substance abuse

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Segmentation by type of abuse
• Global alcohol abuse treatment market
• Global nicotine abuse treatment market
• Global drugs abuse treatment market

PART 08: Geographical segmentation
• Substance abuse market in Americas
• Substance abuse market in EMEA
• Substance abuse market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends

PART 12: Vendor landscape
• Competitive scenario

PART 13: Key vendor analysis
• Alkermes
• Allergan
• GSK
• Pfizer
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Substance abuse: An insight
Exhibit 02: Overview: Global substance abuse market
Exhibit 03: Major diseases associated with substance abuse
Exhibit 04: Global substance abuse treatment market: Snapshot
Exhibit 05: Global substance abuse treatment market 2016-2021 ($ million)
Exhibit 06: Opportunity analysis: Global substance abuse treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Global substance abuse treatment market by type of abuse 2016
Exhibit 09: Global alcohol abuse treatment market 2016-2021 ($ million)
Exhibit 10: Global nicotine abuse treatment market 2016-2021 ($ million)
Exhibit 11: Drugs illicitly used worldwide
Exhibit 12: Global drug abuse treatment market 2016-2021 ($ million)
Exhibit 13: Global substance abuse treatment market by geography 2016 and 2021
Exhibit 14: Global substance abuse treatment market by geography 2016-2021 ($ million)
Exhibit 15: Market scenario in Americas
Exhibit 16: Substance abuse treatment market in Americas 2016-2021 ($ million)
Exhibit 17: Market Scenario in EMEA
Exhibit 18: Substance abuse treatment market in EMEA 2016-2021 ($ million)
Exhibit 19: Market Scenario in APAC
Exhibit 20: Substance abuse treatment market in APAC 2016-2021 ($ million)
Exhibit 21: Various approaches in substance abuse treatment
Exhibit 22: Factors contributing to overall cost of substance abuse treatment
Exhibit 23: Reasons for poor patient compliance
Exhibit 24: Rehabilitation center acquisitions in recent years
Exhibit 25: Competitive structure analysis of global substance abuse treatment market 2016
Exhibit 26: Competitive factors in global substance abuse treatment market
Exhibit 27: Market penetration of vendors in global substance abuse treatment market 2016
Exhibit 28: Strategic success factors of companies in global substance abuse treatment market
Exhibit 29: Alkermes: Strength assessment
Exhibit 30: Alkermes: Strategy assessment
Exhibit 31: Alkermes: Opportunity assessment
Exhibit 32: Allergan: Key highlights
Exhibit 33: Allergan: Strength assessment
Exhibit 34: Allergan: Strategy assessment
Exhibit 35: Allergan: Opportunity assessment
Exhibit 36: GSK: Key highlights
Exhibit 37: GSK: Strength assessment
Exhibit 38: GSK: Strategy assessment
Exhibit 39: GSK: Opportunity assessment
Exhibit 40: Pfizer: Key highlights
Exhibit 41: Pfizer: Strength assessment
Exhibit 42: Pfizer: Strategy assessment
Exhibit 43: Pfizer: Opportunity assessment



【掲載企業】

Alkermes, Allergan, GSK, Pfizer, Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma, and Teva Pharmaceutical.

【資料のキーワード】

物質乱用、物質乱用治療

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[物質乱用治療の世界市場2017-2021] (Global Substance Abuse Treatment Market 2017-2021 / IRTNTR13568)販売に関する免責事項
[物質乱用治療の世界市場2017-2021] (Global Substance Abuse Treatment Market 2017-2021 / IRTNTR13568)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆